Lavacchi, D.; Pellegrini, E.; Palmieri, V.E.; Doni, L.; Mela, M.M.; Di Maida, F.; Amedei, A.; Pillozzi, S.; Carini, M.; Antonuzzo, L.
Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective. Int. J. Mol. Sci. 2020, 21, 4691.
https://doi.org/10.3390/ijms21134691
AMA Style
Lavacchi D, Pellegrini E, Palmieri VE, Doni L, Mela MM, Di Maida F, Amedei A, Pillozzi S, Carini M, Antonuzzo L.
Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective. International Journal of Molecular Sciences. 2020; 21(13):4691.
https://doi.org/10.3390/ijms21134691
Chicago/Turabian Style
Lavacchi, Daniele, Elisa Pellegrini, Valeria Emma Palmieri, Laura Doni, Marinella Micol Mela, Fabrizio Di Maida, Amedeo Amedei, Serena Pillozzi, Marco Carini, and Lorenzo Antonuzzo.
2020. "Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective" International Journal of Molecular Sciences 21, no. 13: 4691.
https://doi.org/10.3390/ijms21134691
APA Style
Lavacchi, D., Pellegrini, E., Palmieri, V. E., Doni, L., Mela, M. M., Di Maida, F., Amedei, A., Pillozzi, S., Carini, M., & Antonuzzo, L.
(2020). Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective. International Journal of Molecular Sciences, 21(13), 4691.
https://doi.org/10.3390/ijms21134691